Vikram Rajan

Experience

• 

  Deloitte Consulting LLP

  Jan 2015 - Jan 2019

  Created, sold, and executed on intellectual property (IP) management strategies for clients transitioning to digital supply chains enabled by advanced manufacturing. (Early promotion to Senior Consultant)Key Accomplishments:• Developed digital sourcing strategy to guide client organization with $40bn+ global supply chain in digitally manufactured parts, unlocking $100mms in value for customers through reduced vehicle and equipment downtime• Designed and ran negotiation simulation and contracting workshop for senior-level Fortune 100 attendees, on behalf of client per urgent request• Invited to present at national conferences to hundreds of attendees as digital IP subject matter expert (SME) Show less Credited with $4.8mm+ in sales. Generated multimillion-dollar pipeline of work in three-person fulltime strategy and sales team by developing new advanced manufacturing service offering and pitching at dozens of sales meetingsKey Accomplishments:• Led team of 14 to organize firm's presence at conference where leadership unveiled new service offering• Authored IP risk management strategy whitepaper - directly quoted in client's statement of work, used in sales meetings and project delivery, and cited in trade and scientific papers• Built innovation strategies for allocating client organization's $400mm budget to field counter-terrorism tech 60%+ faster than traditional channels Show less

  • Consultant

    Jan 2017 - Jan 2019

  • Business Technology Analyst

    Jan 2015 - Jan 2017
• 

  Northwestern Medicine

  Jan 2020 - Jan 2020

  Legal Extern

  Conducted legal analyses on data privacy, contracts, and patient safety that informed the General Counsel's legal advice to CEO and physiciansKey Accomplishments:• Advocated for update to contracting procedure for $6.6bn revenue healthcare system during COVID-19 pandemic, based on independent legal research

• 

  Goldman Sachs

  Jan 2021 - Jan 2021

  Investment Banking Summer Associate

  Key Accomplishment: • Performed quantitative analyses and strategic advisory support for full process of accelerated 5-week, $1.1bn sale of medtech company to strategic buyer

• 

  VCapital Management

  Jan 2021 - Jan 2021

  Venture Capital Intern

  Drafted investment committee memos, performed due diligence, and interviewed CEOs of life sciences and tech companies to guide VCapital's management with Series A/B investmentsKey Accomplishments:• Pitched VCapital investment committee on AI-driven prostate cancer company, Avenda Health, resulting in $10mm Series B lead investment • Engaged founders and CEOs for sourcing deals that underpin ~20% of current portfolio

• 

  Goldman Sachs

  Jan 2022 - Jan 2023

  Investment Banker

  Led teams to develop market evaluations and client financial analyses to guide strategic business development decisions by executive clients (CEOs, founders, and boards). Supported ~$3bn in total deal value across biotech, diagnostics, and medtechKey accomplishments: • Built financial model to dynamically value and compare multiple bids for partnership and sale of ~$2bn clinical-stage biotech, ranging from upfront cash to bids including contingent value rights (CVRs) and milestones • Crafted tailored strategic guidance for CEO of $30.0bn+, next generation genetic sequencer company to defend against activist investor amidst unfavorable legal rulings on acquisition Show less

• 

  Stratospheric

  Jan 2023 - now

  Founder and Managing Partner

  Founded advisory practice to engage customers building technology-forward high-growth businesses across industries.Key accomplishments: • Provided in person advisory support for tech startup at invite-only New York Stock Exchange (NYSE) event, resulting in connections with potential partners and funders. • Guided outreach strategy for ultra high net worth client planning bid for minority ownership stake in top 15 most valuable professional US sports teams. • Created investment memorandum for VC client considering equity stakes in early-stage biotech and energy startups. Show less

• 

  Cosette Pharmaceuticals, Inc.

  Jan 2024 - now

  Senior Manager, Business Development

  Sourcing, evaluating, negotiating, and contracting for opportunities to acquire and license branded specialty pharmaceutical products.Key deals: • Acquisition offer for Mayne Pharma -- Announced $430mm cash offer to buy public, global specialty pharmaceutical company with focus on women's health and dermatology. • Equity recapitalization -- Hamilton Lane, an ~$1tn AUM investment firm, made a significant direct equity investment in Cosette Pharmaceuticals, while maintaining prior sole investor, Avista Healthcare Partners. Show less